Ara
Toplam kayıt 5, listelenen: 1-5
Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19
(Wiley, 2021)
Hydroxychloroquine (HCQ) and azithromycin (AZM) are widely used in off‐label treatment of novel coronavirus disease (COVID‐19). However, cardiac safety of these drugs is still controversial in COVID‐19. Therefore, we aimed ...
Permanent atrial fibrillation portends poor outcomes in hospitalized patients with COVID-19: A retrospective observational study
(Elsevier, 2021)
Background: Data specifically addressed to whether atrial fibrillation (AF) would contribute to increasing the risk for severe forms of novel coronavirus disease (COVID-19) or worse prognosis remain unclear. Hence, we ...
Fragmented QRS is a marker of mortality in patients with severe COVID-19: A retrospective observational study
(TURKISH SOCIETY CARDIOLOGY, 2021)
Objective: In this study, we aimed to investigate the association of fragmented QRS (f-QRS) with in-hospital death in patients with severe novel coronavirus disease 2019 (COVID-19).
Methods: This was a retrospective and ...
Prognostic implication of uncontrolled hypertension in hospitalized patients with COVID-19
(CZECH SOC CARDIOLOGY & CZECH SOC CARDIOVASCULAR SURGERY, 2021)
Objective: In this study, we aimed to investigate the effect of hypertension (HT) and antihypertensive treatment on prognosis, which is one of the cardiovascular risk factors affecting the prognosis of COVID-19.
Methods: ...
Reply to Letter to the Editor: "How Does SARS-CoV-2 Fragment the QRS?"
(NLM (Medline), 2022)
Letter to Editor